Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Recent evidence suggests that there is a link between metabolic diseases and bacterial populations in the gut. The aim of this study was to assess the differences between the composition of the intestinal microbiota in humans with type 2 diabetes and non-diabetic persons as control. METHODS AND FINDINGS: The study included 36 male adults with a broad range of age and body-mass indices (BMIs), among which 18 subjects were diagnosed with diabetes type 2. The fecal bacterial composition was investigated by real-time quantitative PCR (qPCR) and in a subgroup of subjects (N = 20) by tag-encoded amplicon pyrosequencing of the V4 region of the 16S rRNA gene. The proportions of phylum Firmicutes and class Clostridia were significantly reduced in the diabetic group compared to the control group (P = 0.03). Furthermore, the ratios of Bacteroidetes to Firmicutes as well as the ratios of Bacteroides-Prevotella group to C. coccoides-E. rectale group correlated positively and significantly with plasma glucose concentration (P = 0.04) but not with BMIs. Similarly, class Betaproteobacteria was highly enriched in diabetic compared to non-diabetic persons (P = 0.02) and positively correlated with plasma glucose (P = 0.04). CONCLUSIONS: The results of this study indicate that type 2 diabetes in humans is associated with compositional changes in intestinal microbiota. The level of glucose tolerance should be considered when linking microbiota with metabolic diseases such as obesity and developing strategies to control metabolic diseases by modifying the gut microbiota.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Compelling evidence have shown that the composition of the gut microbiota is altered in animal models of obesity and subjects with prediabetes or type 2 diabetes compared with controls (182–186).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [183]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Chronic autoimmune inflammatory diseases, including celiac disease,17 type 2 diabetes18 and obesity19 are associated with intestinal dysbiosis.”
From Probiotics and the gut microbiota in intestinal health and disease (2010) · cites this paper as [18]
In the citing paper
“Conversely, heterocyclic amines and glycan derived from red meat may promote inflammation in gut health due to higher concentration of Bacteroides and Fusobacterium and lower levels of Lactobacillus and Roseburia, which are also linked with lower anti-inflammatory responses and increased incidence of type 2 diabetes [191,192,193].”
From Impact of Protein Intake in Older Adults with Sarcopenia and Obesity: A Gut Microbiota Perspective (2020) · cites this paper as [191]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
[RETRACTION]Translational research into gut microbiota: new horizons in obesity treatment
Tsukumo, D. M., Carvalho, B. M., Carvalho-Filho, M. A., & Saad, M. J. A. (2009) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302009000200004 · Cited by 44
RetractedTranslational research into gut microbiota: new horizons in obesity treatment
Tsukumo, D. M. L., Carvalho, B. M., Filho, C., & Saad, M. J. A. (2013) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302013000900014 · Cited by 17
RetractedAn obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 1×
“The differences in microbial composition were explained by an increased capacity of the obesity-associated microbiome to harvest energy from the diet [13].”
BackgroundA core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176
The Ribosomal Database Project: improved alignments and new tools for rRNA analysis
Cole, J. R., Wang, Q., Cardenas, E., Fish, J., Chai, B., Farris, R. J., Kulam-Syed-Mohideen, A. S., McGarrell, D. M., Marsh, T., Garrity, G. M., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn879 · Cited by 4,762
Inflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143
Cani, P. D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., Geurts, L., Naslain, D., Neyrinck, A., Lambert, D. M., et al. (2009) · Gut · doi:10.1136/gut.2008.165886 · Cited by 2,518 · cited 2×
“For example, levels of Bifidobacterium significantly and positively correlated with improved glucose-tolerance and low-grade inflammation in prebiotic treated-mice [1,6].”
BackgroundMicrobiota and SCFA in lean and overweight healthy subjects
Schwiertz, A., Taras, D., Schäfer, K., Beijer, S., Bos, N. A., Donus, C., & Hardt, P. D. (2010) · Obesity · doi:10.1038/oby.2009.167 · Cited by 2,457
Cited by
Items 601–700 of 1,020
Microbiota abnormalities in inflammatory airway diseases — Potential for therapy
Gollwitzer, E. S., & Marsland, B. J. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.08.002 · Cited by 100
“However, not only intestinal disease but also other disorders such as obesity (Tilg & Kaser, 2011) or type 2 diabetes (Larsen et al., 2010) are linked to dysbiosis of the intestinal microbiota, highlighting the importance of an intact microbial community and diversity in the intestine for systemic…”
BackgroundQu, L., Ren, J., Huang, L., Pang, B., Liu, X., Liu, X., Li, B., & Shan, Y. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b04874 · Cited by 102
Metabolites Linking the Gut Microbiome with Risk for Type 2 Diabetes
Zhu, T., & Goodarzi, M. O. (2020) · Current Nutrition Reports · doi:10.1007/s13668-020-00307-3 · Cited by 118
Murray, E. R., Kemp, M., & Nguyen, T. T. (2022) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acac008 · Cited by 92
“In addition, Bacteroides has previously been found to be linked with chronic illnesses that are known risk factors for ad, such as diabetes (Larsen et al., 2010), and other neurodegenerative disorders such as Parkinson’s Disease (Keshavarzian et al.”
BackgroundDietary‐resistant starch improves maternal glycemic control in Goto–Kakizaki rat
Shen, L., Keenan, M. J., Raggio, A., Williams, C., & Martin, R. J. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201000605 · Cited by 101
“Second, augmented butyrate-producing bacterial population was confirmed except for Clostridial cluster XIV which might be due to its absolute reduction in type 2 diabetes [35].”
Impact of Protein Intake in Older Adults with Sarcopenia and Obesity: A Gut Microbiota Perspective
Prokopidis, K., Cervo, M. M., Gandham, A., & Scott, D. (2020) · Nutrients · doi:10.3390/nu12082285 · Cited by 99
Repeated sleep disruption in mice leads to persistent shifts in the fecal microbiome and metabolome
Bowers, S. J., Vargas, F., González, A., He, S., Jiang, P., Dorrestein, P. C., Knight, R. D., Wright, K. P., Lowry, C. A., Fleshner, M., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0229001 · Cited by 105
The role of the microbiome in diabetes mellitus
Zhang, S., Cai, Y., Meng, C., Ding, X., Huang, J., Luo, X., Cao, Y., Gao, F., & Zou, M. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108645 · Cited by 109
Krych, Ł., Kot, W., Bendtsen, K. M., Hansen, A. K., Vogensen, F. K., & Nielsen, D. S. (2017) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2017.10.015 · Cited by 99
Self-citationZheng, J., Cheng, G., Li, Q., Jiao, S., Feng, C., Zhao, X., Yin, H., Du, Y., & Liu, H. (2018) · Marine Drugs · doi:10.3390/md16020066 · Cited by 102
“In other studies, a low F/B ratio was identified in obese mice or people [46,47].”
Tsai, C.-Y., Lu, H.-C., Chou, Y.-H., Liu, P.-Y., Chen, H.-Y., Huang, M.-C., Lin, C.-H., & Tsai, C.-N. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.814770 · Cited by 92
“To analyze gut microbiota in our T2D cases with mild to moderate gut microbial dysbiosis, Bacteroidetes and Firmicutes were the dominant phyla, similar to healthy populations (41).”
BackgroundRole of microbiota short-chain fatty acids in the pathogenesis of autoimmune diseases
Rasouli‐Saravani, A., Jahankhani, K., Moradi, S., Gorgani, M., Shafaghat, Z., Mirsanei, Z., Mehmandar‐Oskuie, A., & Mirzaei, R. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114620 · Cited by 107
Wang, Y., Chen, J., Song, Y., Zhao, R., Xia, L., Chen, Y., Cui, Y.-P., Rao, Z., Zhou, Y., Zhuang, W., et al. (2019) · Nutrition and Diabetes · doi:10.1038/s41387-019-0086-9 · Cited by 109
Peng, W., Huang, J., Yang, J., Zhang, Z., Yu, R., Fayyaz, S., Zhang, S., & Qin, Y. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.03141 · Cited by 107
Low Fibre Intake is Associated with Gut Microbiota Alterations in Chronic Heart Failure
Mayerhofer, C. C. K., Kummen, M., Holm, K., Broch, K., Awoyemi, A., Vestad, B., Storm-Larsen, C., Seljeflot, I., Ueland, T., Bohov, P., et al. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12596 · Cited by 107
Acute Sleep-Wake Cycle Shift Results in Community Alteration of Human Gut Microbiome
Liu, Z., Wei, Z.-Y., Chen, J., Chen, K., Mao, X., Liu, Q., Sun, Y., Zhang, Z., Zhang, Y., Dan, Z., et al. (2020) · mSphere · doi:10.1128/msphere.00914-19 · Cited by 94
“Dysbiosis of the gut microbiome is known to be associated with diabetes, metabolic disorders, and fat storage (10, 11), as well as impaired cognitive performance through the gut-brain axis (12–14).”
BackgroundMaki, K. A., Burke, L., Calik, M. W., Watanabe‐Chailland, M., Sweeney, D., Romick‐Rosendale, L. E., Green, S. J., & Fink, A. M. (2020) · Physiological Genomics · doi:10.1152/physiolgenomics.00039.2020 · Cited by 103
Microbiota and Diabetes Mellitus: Role of Lipid Mediators
Salazar, J. J., Angarita, L., Morillo, V., Navarro, C., Martínez, M. S., Chacín, M., Torres, W., Rajotia, A., Rojas, M., Cano, C., et al. (2020) · Nutrients · doi:10.3390/nu12103039 · Cited by 108
“These differences in “metabolic usefulness” of the Firmicutes/Bacteroidetes ratio have also been seen in diabetic patients, in which an increased concentration of Bacteroidetes and a decrease in Firmicutes has been observed [70].”
BackgroundSun, Y., Hua-qi, H., Wang, Q., Yang, X., Jiang, S., & Wang, D. (2022) · Polymers · doi:10.3390/polym14204454 · Cited by 99
“A decrease in Bacteroides and an increase in Firmicutes abundance are generally associated with increased dietary energy absorption and lower levels of inflammation [165], and the ratio of Bacteroides/Firmutes was positively correlated with blood glucose concentration [166].”
BackgroundProbiotics as beneficial agents in the management of diabetes mellitus: a systematic review
Razmpoosh, E., Javadi, M., Ejtahed, H., & Mirmiran, P. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2665 · Cited by 95
“In animal studies, it has been confirmed that probiotic treatment improves insulin-binding potential in T2DM mouse models and also inhibits β-cells destruction in the islets of Langerhans in diabetic mice [12,13] and moreover increases insulin sensitivity by promoting the transcription of glucose transporter 4 [14].”
BackgroundInfluentialDubourg, G., Lagier, J., Hüe, S., Surénaud, M., Bachar, D., Robert, C., Michelle, C., Ravaux, I., Mokhtari, S., Million, M., et al. (2016) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2016-000080 · Cited by 106
de Moraes, A. C. F., de Almeida-Pititto, B., Fernandes, G. D. R., Gomes, E. P., Pereira, A. C., & Ferreira, S. R. G. (2017) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-017-0261-x · Cited by 102
“However, our result is concordant with a report of an association of high abundance of Bacilli with the western diet [53] and diabetes [54], both conditions associated with low-grade inflammation and insulin resistance.”
ResultMoon, J., Zolnik, C. P., Wang, Z., Qiu, Y., Usyk, M., Wang, T., Kizer, J. R., LANDAY, A. L., Kurland, I. J., Anastos, K., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.10.037 · Cited by 104
“These findings are generally consistent with most previous studies that examined the relationship between gut microbiota and diabetes in HIV-uninfected populations [2,42,43].”
ResultHuman Gut Microbiota in Health and Alzheimer’s Disease
Szablewski, L. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170908 · Cited by 91
Liu, G., Bei, J., Liang, L., Yu, G., Li, L., & Li, Q.-H. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700954 · Cited by 85
Relationship between the microbiome and ocular health
Cavuoto, K. M., Banerjee, S., & Galor, A. (2019) · The Ocular Surface · doi:10.1016/j.jtos.2019.05.006 · Cited by 99
Mosterd, C. M., Kanbay, M., van den Born, B. H., van Raalte, D. H., & Rampanelli, E. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101484 · Cited by 105
The Relationships between Gut Microbiota and Diabetes Mellitus, and Treatments for Diabetes Mellitus
Crăciun, C.-I., Neag, M. A., Cătinean, A., Mitre, A. O., Rusu, A., Bala, C. G., Román, G., Buzoianu, A. D., Muntean, D. M., & Craciun, A. E. (2022) · Biomedicines · doi:10.3390/biomedicines10020308 · Cited by 106
Dheer, R., Patterson, J., Dudash, M., Stachler, E. N., Bibby, K. J., Stolz, D. B., Shiva, S., Wang, Z., Hazen, S. L., Barchowsky, A., et al. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.10.020 · Cited by 97
“Higher levels of Bacilli and Lactobacillus observed in this study were also observed in type II diabetic human adults (Larsen et al., 2010).”
BackgroundBariatric surgery versus intensive medical therapy for diabetes.
Schauer, P. R., Bhatt, D. L., & Kashyap, S. (2014) · PubMed · doi:10.1056/nejmc1407393 · Cited by 35
Variations of Tongue Coating Microbiota in Patients with Gastric Cancer
Hu, J., Han, S., Chen, Y., & Zhao-ning, J. (2015) · BioMed Research International · doi:10.1155/2015/173729 · Cited by 99
“To control for factors that may influence the microbiota of tongue coatings, we included BMI [21], diabetes [22], and hypertension [6], which may influence the human body microbial community, and smoking [23] and drinking [24], whichmay be associatedwith the risk of gastric cancer, in the statistical analysis.”
BackgroundGong, J., & Yang, C. (2012) · Food Research International · doi:10.1016/j.foodres.2011.12.027 · Cited by 108
Ellekilde, M., Krych, Ł., Hansen, C. H. F., Hufeldt, M. R., Dahl, K., Hansen, L. H., Sørensen, S. J., Vogensen, F. K., Nielsen, D. S., & Hansen, A. K. (2014) · Research in Veterinary Science · doi:10.1016/j.rvsc.2014.01.007 · Cited by 99
“PCR amplification of the 16S rRNA gene, purification and pyrosequencing of amplified PCR products were done as previously described (Larsen et al., 2010).”
MethodSelf-citationGut microbiome interventions in human health and diseases
Nie, P., Li, Z., Wang, Y., Zhang, Y., Zhao, M., Luo, J., Du, S., Deng, Z., Chen, J., Wang, Y., et al. (2019) · Medicinal Research Reviews · doi:10.1002/med.21584 · Cited by 99
From role of gut microbiota to microbial-based therapies in type 2-diabetes
Ebrahimzadeh Leylabadlo, H., Sanaie, S., Sadeghpour Heravi, F., Ahmadian, Z., & Ghotaslou, R. (2020) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2020.104268 · Cited by 92
C57BL/6J substrain differences in response to high-fat diet intervention
Siersbæk, M. S., Ditzel, N., Hejbøl, E. K., Præstholm, S. M., Markussen, L. K., Avolio, F., Li, L., Lehtonen, L., Hansen, A. K., Schrøder, H. D., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-70765-w · Cited by 103
Tabrizi, R., Moosazadeh, M., Lankarani, K. B., Akbari, M., Heydari, S. T., Kolahdooz, F., & Asemi, Z. (2017) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-017-9299-1 · Cited by 95
“The alterations in gut microbiota have recently been reported in subjects with T2DM, and this may be reversible with probiotic intake [21].”
BackgroundProbiotic Use in Horses – What is the Evidence for Their Clinical Efficacy?
Schoster, A., Weese, J. S., & Guardabassi, L. (2014) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.12451 · Cited by 117
Compositional dynamics of the human intestinal microbiota with aging: Implications for health
Lakshminarayanan, B., Stanton, C., O'Toole, P. W., & Ross, R. P. (2014) · The Journal of nutrition, health and aging · doi:10.1007/s12603-014-0549-6 · Cited by 89
Tyler, A. D., Knox, N., Kabakchiev, B., Milgrom, R., Kirsch, R., Cohen, Z., McLeod, R. S., Guttman, D. S., Krause, D. O., & Silverberg, M. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066934 · Cited by 94
“Recent studies have implicated microorganisms in the etiology of several chronic conditions including inflammatory bowel disease (IBD) [1], diabetes [2] and obesity [3].”
BackgroundKellow, N. J., Coughlan, M. T., Savige, G. S., & Reid, C. M. (2014) · BMC Endocrine Disorders · doi:10.1186/1472-6823-14-55 · Cited by 89
“Furthermore, the total quantity and relative proportions of distinct bacterial species found in the colon differ between lean and obese individuals as well as between individuals with and without diabetes [32,33].”
BackgroundThe alteration of gut microbiota in newly diagnosed type 2 diabetic patients
Chen, P., Chien, Y., & Yang, S. (2018) · Nutrition · doi:10.1016/j.nut.2018.11.019 · Cited by 99
Gut Microbiome Signatures Are Biomarkers for Cognitive Impairment in Patients With Ischemic Stroke
Ling, Y., Gong, T., Zhang, J., Gu, Q., Gao, X., Weng, X., Liu, J., & Sun, J. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.511562 · Cited by 101
The Human Virome: Viral Metagenomics, Relations with Human Diseases, and Therapeutic Applications
Bai, G.-H., Lin, S., Hsu, Y., & Chen, S.-Y. (2022) · Viruses · doi:10.3390/v14020278 · Cited by 100
Zádori, Z., Király, K. P., Al‐Khrasani, M., & Gyires, K. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108327 · Cited by 99
Ivey, K. L., Hodgson, J. M., Kerr, D. A., Lewis, J. R., Thompson, P. L., & Prince, R. (2014) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2013.294 · Cited by 98
Probiotics for human health –new innovations and emerging trends
Grover, S., Rashmi, H. M., Srivastava, A. K., & Batish, V. K. (2012) · Gut Pathogens · doi:10.1186/1757-4749-4-15 · Cited by 87
“In order to substantiate the validity of this hypothesis, he came across with some observations that microbial populations in the gut are different in obese and lean subjects and similarly in diabetic from nondiabetics suggesting that obesity/diabetes may have a different microbial component [18].”
ResultDoes Our Gut Microbiome Predict Cardiovascular Risk?: A Review of the Evidence From Metabolomics
Griffin, J. L., Wang, X., & Stanley, E. (2015) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.114.000219 · Cited by 92
Davies, N., O'Sullivan, J. M., Plank, L. D., & Murphy, R. (2019) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.01.033 · Cited by 102
The Impact of Diet on Immunity and Respiratory Diseases
Wypych, T. P., Marsland, B. J., & Ubags, N. D. J. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201703-255aw · Cited by 104
Liu, J., Segovia, I., Yuan, X., & Gao, Z. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030910 · Cited by 100
“healthy individuals [25], with a ~30% decrease in fecal contents of propionate and butyrate in T2D subjects [26].”
BackgroundRavikumar, Y., Ponpandian, L. N., Zhang, G., Yun, J., & Qi, X. (2020) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2020.11.020 · Cited by 94
The Interplay between Immune System and Microbiota in Inflammatory Bowel Disease: A Narrative Review
Aldars‐García, L., Marín, A. C., Chaparro, M., & Gisbert, J. P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063076 · Cited by 98
“Gut dysbiosis is linked to many diseases, including IBD [29], type 2 diabetes [30], cardiovascular diseases [31], and neuropsychological conditions triggered through the “gut-brain axis” [32].”
BackgroundThe gut microbiome and type 2 diabetes status in the Multiethnic Cohort
Maskarinec, G., Raquinio, P., Kristal, B. S., Setiawan, V. W., Wilkens, L. R., Franke, A. A., Lim, U., Marchand, L. L., Randolph, T. W., Lampe, J. W., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0250855 · Cited by 94
“Greater abundance of gram-negative, endotoxin-producing bacteria in the Escherichia-Shigella group (which includes E. coli) [7, 34, 38] and other Proteobacteria [8, 39] among T2D patients have been reported previously.”
BackgroundResultInfluentialZhang, Y., Wang, L., Zhang, J., Li, Y., He, Q., Li, H., Guo, X., Guo, J., & Zhang, H. (2013) · European Journal of Nutrition · doi:10.1007/s00394-013-0519-5 · Cited by 98
“[24] clinical study that plasma glucose concentration of type 2 diabetes is closely related to relatively less Bacteroidetes.”
BackgroundTan, C., Wei, H., Ao, J., Long, G. Q., & Peng, J. (2016) · Applied and Environmental Microbiology · doi:10.1128/aem.01374-16 · Cited by 93
“The abundance of Firmicutes was lower in diabetic persons than in their nondiabetic counterparts (44).”
BackgroundGood or bad: gut bacteria in human health and diseases
Wang, H., Wei, C.-X., Lu, M., & Zhu, L. (2018) · Biotechnology & Biotechnological Equipment · doi:10.1080/13102818.2018.1481350 · Cited by 96
Zhang, M., Feng, R., Yang, M., Cheng, Q., Wang, Z., Liu, W., & Ma, J. (2019) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000717 · Cited by 94
Lü, C., Hu, Z., Wang, R., Hong, Z.-H., Lü, J., Chen, P., Zhang, J.-X., Li, X., Yuan, B.-Y., Huang, S., et al. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-019-0326-5 · Cited by 97
Que, Y., Cao, M., He, J., Zhang, Q., Chen, Q., Yan, C., Lin, A., Yang, L., Wu, Z., Zhu, D., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.722206 · Cited by 98
“found that the proportions of the phylum Firmicutes and class Clostridia were significantly reduced in T2DM patients compared to the control group (10); whereas one Pakistani study with 60 individuals revealed that bacteria from Firmicutes along with those from Clostridia and Negativicutes were predominant in obese T2…”
ResultMetagenomic analysis of Surti buffalo (Bubalus bubalis) rumen: a preliminary study
Singh, K. M., Ahir, V. B., Tripathi, A. K., Ramani, U. V., Sajnani, M. R., KORINGA, P. G., Jakhesara, S. J., PANDYA, P. R., Rank, D. N., Murty, D. S., et al. (2011) · Molecular Biology Reports · doi:10.1007/s11033-011-1278-0 · Cited by 98
“One approach has been the use of the pyrosequence technology to increase the depth of SSU rRNA surveys by sequencing amplicons from the variable region of the SSU molecule [11–13].”
MethodHays, R., Esterman, A., Giacomin, P., Loukas, A. C., & McDermott, R. A. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.01.012 · Cited by 97
“microbiota is altered in patients with diabetes compared to those without diabetes [18] and animal studies have demonstrated the effect that helminths may have on gut bacteria [19].”
BackgroundMechanisms of the intestinal and urinary microbiome in kidney stone disease
Miller, A. W., Penniston, K. L., Fitzpatrick, K., Agudelo, J., Tasian, G., & Lange, D. (2022) · Nature Reviews Urology · doi:10.1038/s41585-022-00647-5 · Cited by 89
Analyzing the Human Microbiome: A “How To” guide for Physicians
Tyler, A. D., Smith, M. I., & Silverberg, M. S. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.73 · Cited by 81
From trash to treasure: detecting unexpected contamination in unmapped NGS data
Sangiovanni, M., Granata, I., Thind, A. S., & Guarracino, M. R. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-2684-x · Cited by 98
Rapid gut microbiome changes in a world‐class ultramarathon runner
Grosicki, G. J., Durk, R. P., & Bagley, J. R. (2019) · Physiological Reports · doi:10.14814/phy2.14313 · Cited by 97
“Subsequent findings have demonstrated compelling relationships between human gut microbiome composition and many leading causes of death worldwide including cardiovascular disease (Wang et al., 2011), diabetes (Larsen et al., 2010), and cancer (Ahn et al., 2013).”
BackgroundSahle, Z., Engidaye, G., Shenkute, D., Adenew, B., & Asfaw, T. (2024) · SAGE Open Medicine · doi:10.1177/20503121241257486 · Cited by 99
“109 110–112 These improvements are thought to be mediated by changes in the gut microbiota that positively influence metabolic function.”
BackgroundKelder, T., Stroeve, J. H. M., Bijlsma, S., Radonjic, M., & Roeselers, G. (2014) · Nutrition & Diabetes · doi:10.1038/nutd.2014.18 · Cited by 86
Is metformin poised for a second career as an antimicrobial?
Malik, F. R., Mehdi, S. F., Ali, H., Patel, P., Basharat, A., Kumar, A., Ashok, F., Stein, J., Brima, W., Malhotra, P., et al. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2975 · Cited by 96
Snelson, M., Kellow, N. J., & Coughlan, M. T. (2018) · Advances in Nutrition · doi:10.1093/advances/nmy068 · Cited by 96
“Dysbiosis in CKD Many diseases have been associated with alterations in the gut microbiota including liver disease (7), hypertension (8), obesity (9), and insulin resistance (10).”
BackgroundProbiotics and blood pressure: current insights
Sudha, R., & Upadrasta, A. (2016) · Integrated Blood Pressure Control · doi:10.2147/ibpc.s73246 · Cited by 80
“The influence of GIT microbiota composition and their possible link to obesity, 42 diabetes, 43,44 neural disorders, 45,46 brain development, 47 insulin resistance, and other metabolic disorders 48 have been well documented.”
BackgroundHu, T., Wen, P., Shen, W., Liu, F., Li, Q., Erna, L., Liao, S., Wu, H., & Zou, Y. (2019) · Journal of Natural Products · doi:10.1021/acs.jnatprod.9b00205 · Cited by 92
Yang, Q., Huang, X., Wang, P., Yan, Z., Sun, W., Zhao, S., & Gun, S. (2019) · MicrobiologyOpen · doi:10.1002/mbo3.923 · Cited by 91
“…spp., which have been reported to perform crucial functions in maintaining the intestinal health or disease of newborn animals (Bordin et al., 2013; Larsen et al., 2010), were selected for absolute quantification qPCR using previously validated bacterial group-specific 16S primers (Table A1).”
MethodCheng, S., Han, B., Ding, M., Wen, Y., Ma, M., Zhang, L., Qi, X., Cheng, B., Li, P., Kafle, O. P., et al. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbz034 · Cited by 90
Diamante, G., Cely, I., Zamora, Z., Ding, J., Blencowe, M., Lang, J., Bline, A. P., Singh, M., Lusis, A. J., & Yang, X. (2020) · Environment International · doi:10.1016/j.envint.2020.106260 · Cited by 95
“A fall in Bifidobacteria and certain Clostridia groups have also been observed in response to both perinatal and direct BPA exposure and decreases in these bacteria are linked to obesity and diabetes (Larsen et al., 2010; Lai et al., 2016; Malaise et al., 2017).”
Intestinal aganglionosis is associated with early and sustained disruption of the colonic microbiome
Ward, N. L., Pieretti, A., Dowd, S. E., Cox, S. B., & Goldstein, A. M. (2012) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2012.01937.x · Cited by 85
Ciubotaru, I., Green, S. J., Kukreja, S. C., & Barengolts, E. I. (2015) · Translational research · doi:10.1016/j.trsl.2015.06.015 · Cited by 116
Jayakumar, S., & Loomba, R. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15314 · Cited by 84
Martoni, C. J., Labbé, A., Ganopolsky, J. G., Prakash, S., & Jones, M. L. (2015) · Gut Microbes · doi:10.1080/19490976.2015.1005474 · Cited by 87
Ramos, C., Gibson, G. R., Walton, G., Magistro, D., Kinnear, W., & Hunter, K. A. (2022) · Nutrients · doi:10.3390/nu14030674 · Cited by 91
“Dysbiosis has been associated with several diseases and conditions that are prevalent in older adults, such as diabetes type 2 [41], inflammatory bowel diseases (IBD) [42], frailty [25], insulin resistance [43], atherosclerosis and stroke [44,45], dementia [46], hypertension [47], Alzheimer’s disease [48], Parkinson’s…”
BackgroundLiu, X., Luo, D., Guan, J., Chen, J., & Xu, X. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1087826 · Cited by 94
“In patients with type 2 diabetes, Firmicutes and Clostridia are obviously reduced, while Proteobacteria and Bacteroidetes are increased, compared with those in healthy individuals (84).”
BackgroundCurrent Perspectives on Antihypertensive Probiotics
Daliri, E. B., Lee, B. H., & Oh, D. (2016) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-016-9241-y · Cited by 91
Sheng, Y., Zheng, S., Ma, T., Zhang, C., Ou, X., He, X., Xu, W., & Huang, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-12245-2 · Cited by 92
Lin, G., Liu, X., Yan, X., Liu, D., Yang, C., Liu, B., Huang, Y., & Zhao, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms20010025 · Cited by 87
“And Bacteroides and Proteus were lower compared with normal people based on the previous reports, which showed that microorganisms residing in the intestinal tract participated in the metabolic process of various nutrients in the host body [25].”
ResultYang, Q., Ouyang, J., Sun, F., & Yang, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.590685 · Cited by 90
“demonstrated that microbial dysbiosis could provoke changes in composition and distribution of gut microorganisms, particularly intestinal bacterial species in the mucosa, and metabolic activities (37).”
BackgroundZou, Y., Lin, X., Xue, W., Tuo, L., Chen, M.-S., Chen, X.-H., Sun, C., Li, F.-N., Liu, S., Dai, Y., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-90786-3 · Cited by 93
Gut Microbiota: The Missing Link Between Helicobacter pylori Infection and Metabolic Disorders?
Martín‐Núñez, G. M., Cornejo-Pareja, I. M., Clemente‐Postigo, M., & Tinahones, F. J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.639856 · Cited by 97
Martemucci, G., Fracchiolla, G., Muraglia, M., Tardugno, R., Dibenedetto, R. S., & D‘Alessandro, A. G. (2023) · Antioxidants · doi:10.3390/antiox12122091 · Cited by 99
“Distinct modifications in the gut microbiota have been associated with T2D [410]: a noticeable decline in the phylum Firmicutes and Bifidobacterium spp., a positive correlation between plasma glucose and the relationship between Bacteroidetes and Firmicutes , the relationship between…”
Strain/species identification in metagenomes using genome-specific markers
Tu, Q., He, Z., & Zhou, J. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku138 · Cited by 84
“Previous studies have suggested significantly different gut microbiome compositions between T2D patients and healthy individuals (6), as well as a group of microbes significantly associated with T2D patients (8).”
BackgroundCox-York, K. A., Sheflin, A. M., Foster, M. T., Gentile, C. L., Kahl, A., Koch, L. G., Britton, S. L., & Weir, T. L. (2015) · Physiological Reports · doi:10.14814/phy2.12488 · Cited by 84
“12488 Physiol Rep, 3 (8), 2015, e12488, doi: 10.14814/phy2.”
BackgroundInfluentialWu, Y., & Zhang, G. (2018) · LWT · doi:10.1016/j.lwt.2018.03.034 · Cited by 83
Barathikannan, K., Chelliah, R., Rubab, M., Daliri, E. B., Elahi, F., Kim, D.-H., Agastian, P., Oh, S.-Y., & Oh, D. H. (2019) · Microorganisms · doi:10.3390/microorganisms7100456 · Cited by 92
Shifting the paradigm from inhibitors of inflammation to resolvers of inflammation in periodontitis
Dyke, T. E. V. (2020) · Journal of Periodontology · doi:10.1002/jper.20-0088 · Cited by 92
He, B., Nohara, K., Ajami, N. J., Michalek, R. D., Tian, X., Wong, M., Losee-Olson, S. H., Petrosino, J. F., Yoo, S. H., Shimomura, K., et al. (2015) · Scientific Reports · doi:10.1038/srep10604 · Cited by 92
Wong, J. M. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.071639 · Cited by 84
Singh, H., Miyamoto, S., Darshi, M., Torralba, M., Kwon, K., Sharma, K., & Pieper, R. (2020) · Microorganisms · doi:10.3390/microorganisms8091347 · Cited by 86
“investigated the gut microbiome in 170 Chinese patients with T2D and 174 healthy controls and described T2D-associated microbial markers suggesting moderate dysbiosis with an increase in opportunistic pathogens and a decrease in butyrate producers in T2D patients [6,7].”
BackgroundInfluentialLi, Y., Shao, L., Mou, Y., Zhang, Y., & Ping, Y. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1957407 · Cited by 87
“However, reviews have reported inconsistent changes in F/B ratio across a series of neurodegenerative diseases and metabolic disorders, making F/ B ratio a debatable and controversial criterion.(6,99,103,104) In agreement with our findings, one review summarizing the GM alterations in patients with PD found that, at h…”
ResultLin, H., Meng, L., Sun, Z., Shiming, S., Huang, X., Lin, N., Zhang, J., Lu, W., Yang, Q., Chi, J., et al. (2021) · Circulation Heart Failure · doi:10.1161/circheartfailure.120.008220 · Cited by 91
Zhang, C., Jiang, J., Wang, C., Li, S., Yu, L., Tian, F., Zhao, J., Zhang, H., Chen, W., & Zhai, Q. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.11.037 · Cited by 87
Soderborg, T. K., Borengasser, S. J., Barbour, L. A., & Friedman, J. E. (2016) · Diabetologia · doi:10.1007/s00125-016-3880-0 · Cited by 83
“Data characterising intestinal microbiota in patients with type 2 diabetes showed that in addition to reduction of the Firmicutes phylum, the ratio of Bacteroidetes to Firmicutes correlated positively and significantly with plasma glucose concentration but not with BMI [61].”
Influential
Metadata
- Authors
- Larsen, N., Vogensen, F. K., van den Berg, F. W. J., Nielsen, D. S., Andreasen, A. S., Pedersen, B. K., Al-Soud, W. A., Sørensen, S. J., Hansen, L. H., & Jakobsen, M.
- Affiliations
- University of Copenhagen (DK)
- Rigshospitalet (DK)
- Corresponding author
- Larsen, Nadja
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-02-05
- Volume
- 5
- Issue
- 2
- Pages
- e9085
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2816710
- OpenAlex
- W2135989088
- Cited by
- 2,952
- References
- 38
- Citations by year
- 2026: 90 · 2025: 168 · 2024: 217 · 2023: 199 · 2022: 296 · 2021: 331 · 2020: 294 · 2019: 264 · 2018: 191 · 2017: 158 · 2016: 174 · 2015: 150 · 2014: 134 · 2013: 115 · 2012: 83
- FWCI
- 36.90
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Ministeriet for Fø devarer, Landbrug og Fiskeri
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- type 2 diabetes, gut microbiota, Firmicutes, Bacteroidetes, Betaproteobacteria, plasma glucose, glucose tolerance, obesity, metabolic disorders, 16S rRNA gene
- MeSH terms
- Adult, Aged, Bacteria, Diabetes Mellitus, Type 2, DNA, Bacterial, Feces, Humans, Intestines, Male, Middle Aged, RNA, Ribosomal, 16S, Colony Count, Microbial, Body Mass Index, Sequence Analysis, DNA
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.